Literature DB >> 7488156

Novel phosphorylation at a mitotic site, serine 75, in human pp60c-src from unsynchronized human tumor cells having a spherical morphology.

G Kato1, S Maeda.   

Abstract

Endogenous pp60c-src from Y79 unsynchronized human retinoblastoma cells is phosphorylated at an additional N-terminal serine residue relative to unsynchronized fibroblast pp60c-src. We confirmed that the novel phosphorylation site is Ser 75, which is the same as that phosphorylated in overexpressed human pp60c-src during NIH3T3 cell mitosis. We also showed that the Ser 75 phosphorylation pattern correlates with cell rounding in 14 various unsynchronized human tumor cell lines. Especially, pp60c-src from Lu135 having a spherical morphology similar to that of Y79 is phosphorylated as high as Y79 pp60c-src. Mitotic spherical cells of the epithelial-like HepG2 express pp60c-src phosphorylated on Ser 75. On the other hand, Y79 pp60c-src is phosphorylated on Ser 75 throughout the cell cycle. These data suggest that this phosphorylation may be important in spherical cell morphology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488156     DOI: 10.1006/bbrc.1995.2667

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Cdk5 targets active Src for ubiquitin-dependent degradation by phosphorylating Src(S75).

Authors:  Q Pan; F Qiao; C Gao; B Norman; L Optican; Peggy S Zelenka
Journal:  Cell Mol Life Sci       Date:  2011-03-27       Impact factor: 9.261

2.  Nonphosphorylatable Src Ser75 Mutation Increases Ethanol Preference and Consumption in Mice.

Authors:  Goro Kato
Journal:  eNeuro       Date:  2019-04-05

Review 3.  Regulatory Roles of the N-Terminal Intrinsically Disordered Region of Modular Src.

Authors:  Goro Kato
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

4.  A Ser75-to-Asp phospho-mimicking mutation in Src accelerates ageing-related loss of retinal ganglion cells in mice.

Authors:  Kenji Kashiwagi; Sadahiro Ito; Shuichiro Maeda; Goro Kato
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.